Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / lock-up-waiver-consent-broadmark.docx
lock-up-waiver-consent-broadmark.docx
Parties
Penterra Pharmaceuticals Corp
Harkness LLP
Garza LLP
Broadmark Capital Inc
Ridgeline Securities LLC
Waiver Broadmark Capital Inc
Strauss LLP
Castellano Family Holdings LLC
Dates
September 29, 2023
April 17, 2023
October 14, 2023
September 18, 2023
September 19, 2023
August 22, 2023
October 12, 2023
Amounts
$0.001
$22.00
Obligations
Such waiver and release shall become effective as of October 12, 2023 (the "Early Release Date")
Conditions to Consent This consent is conditioned upon, and shall only become effective upon, the satisfaction of each of the following conditions: (a) Registration Statement
The Secondary Offering shall be conducted as a registered selling-stockholder secondary offering under the Company's Form S-3 shelf registration statement (File No
333-274851), and a prospectus supplement relating to the Secondary Offering shall be filed with the SEC in accordance with Rule 424(b) under the Securities Act of 1933, as amended
In no event shall this consent be deemed to apply to any offering of Common Stock that is not conducted pursuant to such shelf registration statement
— shall have delivered their respective written consents to the early release of the lock-up restrictions on terms substantially similar to those set forth in this consent, and copies of such consents shall have been delivered to Broadmark prior to the Early Release Date